These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9711879)

  • 1. Serum hyaluronic acid in clinical practice.
    Tanikawa K
    Intern Med; 1998 Jul; 37(7):565. PubMed ID: 9711879
    [No Abstract]   [Full Text] [Related]  

  • 2. Post-prandial serum hyaluronan concentration in patients with chronic liver disease.
    Idobe Y; Murawaki Y; Ikuta Y; Koda M; Kawasaki H
    Intern Med; 1998 Jul; 37(7):568-75. PubMed ID: 9711881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of serum hyaluronan in patients with chronic viral liver disease.
    Murawaki Y; Ikuta Y; Koda M; Nishimura Y; Kawasaki H
    J Gastroenterol Hepatol; 1996 May; 11(5):459-65. PubMed ID: 8743918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The clinic significance of serum hyaluronate and tumor necrosis factor alpha levels in liver diseases].
    Zou B; Ling Q; Huo J; Lin L; He J; Pan Y
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):97-9. PubMed ID: 10681811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
    Zheng M; Cai W; Weng H; Liu R
    Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Quantitative analysis of serum hyaluronic acid and its application in liver disease].
    Qiang Y; Wang J; Sun W
    Zhonghua Yu Fang Yi Xue Za Zhi; 1995 Jan; 29(1):21-3. PubMed ID: 7600884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Evaluation of non-invasive scores in the follow-up of chronic hepatitis].
    Klein C; Gerken G
    Praxis (Bern 1994); 2005 Apr; 94(16):645-7. PubMed ID: 15900828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic viral hepatitis C. Anatomoclinical and biological correlations].
    Loria A; Giral P; Serfaty L; Guéchot J; Legendre C; Poupon R
    Gastroenterol Clin Biol; 1995 May; 19(5):508-13. PubMed ID: 7590003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The extracellular matrix and liver disease: a study with enzymoimmunological assay].
    Gao F; Kong XT; Wang XL
    Zhonghua Nei Ke Za Zhi; 1994 Feb; 33(2):109-12. PubMed ID: 8070290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of serum hyaluronic acid determination in the diagnosis of liver fibrosis.
    Gudowska M; Cylwik B; Chrostek L
    Acta Biochim Pol; 2017; 64(3):451-457. PubMed ID: 28734086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of serum paraoxonase-1 activity as a potential biomarker for chronic liver impairment.
    Camps J; Marsillach J; Joven J
    Clin Chim Acta; 2007; 386(1-2):114-5. PubMed ID: 17850780
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased serum levels of hyaluronate in liver disease.
    Engström-Laurent A; Lööf L; Nyberg A; Schröder T
    Hepatology; 1985; 5(4):638-42. PubMed ID: 4018736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical evaluation of serum collagen type IV in diagnosing liver fibrosis].
    Feng X; Shen D; Wang J
    Zhonghua Nei Ke Za Zhi; 1995 Jul; 34(7):439-42. PubMed ID: 8556921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The significance of the content of connective tissue metabolites in the blood serum for the diagnosis of chronic viral hepatitis and liver cirrhosis].
    Smirnov BM; Trishkova LA
    Lik Sprava; 1992 Jan; (1):81-4. PubMed ID: 1364619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum hyaluronan as a marker of liver fibrosis.
    Guéchot J; Poupon RE; Poupon R
    J Hepatol; 1995; 22(2 Suppl):103-6. PubMed ID: 7665843
    [No Abstract]   [Full Text] [Related]  

  • 16. High biological variation of serum hyaluronic acid and Hepascore, a biochemical marker model for the prediction of liver fibrosis.
    Rossi E; Adams LA; Ching HL; Bulsara M; MacQuillan GC; Jeffrey GP
    Clin Chem Lab Med; 2013 May; 51(5):1107-14. PubMed ID: 23152415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum hyaluronic acid, procollagen type III and IV in histological diagnosis of liver fibrosis.
    Xie SB; Yao JL; Zheng RQ; Peng XM; Gao ZL
    Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):69-72. PubMed ID: 14607650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
    Crawford DH; Murphy TL; Ramm LE; Fletcher LM; Clouston AD; Anderson GJ; Subramaniam VN; Powell LW; Ramm GA
    Hepatology; 2009 Feb; 49(2):418-25. PubMed ID: 19177571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.